These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 28878291)
41. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma. Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202 [TBL] [Abstract][Full Text] [Related]
42. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer. Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682 [TBL] [Abstract][Full Text] [Related]
43. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway. Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281 [TBL] [Abstract][Full Text] [Related]
44. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334 [TBL] [Abstract][Full Text] [Related]
45. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC. Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753 [TBL] [Abstract][Full Text] [Related]
46. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma. Li Y; Bai M; Xu Y; Zhao W; Liu N; Yu J Cell Physiol Biochem; 2018; 50(5):2004-2016. PubMed ID: 30404076 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer. Lin G; Sun L; Wang R; Guo Y; Xie C J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413 [TBL] [Abstract][Full Text] [Related]
48. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136 [TBL] [Abstract][Full Text] [Related]
49. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway. Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812 [TBL] [Abstract][Full Text] [Related]
51. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer. Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870 [TBL] [Abstract][Full Text] [Related]
52. STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer. Ma Z; Liu D; Li W; Di S; Zhang Z; Zhang J; Xu L; Guo K; Zhu Y; Han J; Li X; Yan X Cell Death Dis; 2019 Jun; 10(6):435. PubMed ID: 31164631 [TBL] [Abstract][Full Text] [Related]
53. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155 [TBL] [Abstract][Full Text] [Related]
54. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway. Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534 [TBL] [Abstract][Full Text] [Related]
55. Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer. Zhang P; Guo X; Li J; Yu S; Wang L; Jiang G; Yang D; Wei Z; Zhang N; Liu J; Sun Y Oncotarget; 2015 May; 6(15):13550-63. PubMed ID: 25948790 [TBL] [Abstract][Full Text] [Related]
56. URGCP promotes non-small cell lung cancer invasiveness by activating the NF-κB-MMP-9 pathway. Cai J; Li R; Xu X; Zhang L; Wu S; Yang T; Fang L; Wu J; Zhu X; Li M; Huang Y Oncotarget; 2015 Nov; 6(34):36489-504. PubMed ID: 26429875 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951 [TBL] [Abstract][Full Text] [Related]
58. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway. Zhu X; Guo X; Wu S; Wei L Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634 [TBL] [Abstract][Full Text] [Related]
59. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma. Han Y; Tian H; Chen P; Lin Q Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994 [TBL] [Abstract][Full Text] [Related]
60. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer. Chen H; Yan S; Dong L; Li X J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]